{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:26:55Z","timestamp":1790281615549,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T00:00:00Z","timestamp":1496102400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Tissue Res"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00441-017-2633-9","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T03:20:32Z","timestamp":1496114432000},"page":"29-39","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Role of TGF-\u03b2 in metastatic colon cancer: it is finally time for targeted therapy"],"prefix":"10.1007","volume":"370","author":[{"given":"Maria","family":"Villalba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie R.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Vidal-Vanaclocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,30]]},"reference":[{"key":"2633_CR1","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1158\/1078-0432.CCR-04-1458","volume":"11","author":"H Alazzouzi","year":"2005","unstructured":"Alazzouzi H, Alhopuro P, Salovaara R, Sammalkorpi H, J\u00e4rvinen H, Mecklin JP, Hemminki A, Schwartz S Jr, Aaltonen LA, Arango D (2005) SMAD4 as a prognostic marker in colorectal cancer. Clin Cancer Res 11:2606\u20132611. doi: 10.1158\/1078-0432.CCR-04-1458","journal-title":"Clin Cancer Res"},{"key":"2633_CR2","first-page":"19","volume":"5","author":"T Armaghany","year":"2012","unstructured":"Armaghany T, Wilson JD, Chu Q, Mills G (2012) Genetic alterations in colorectal cancer. Gastrointest Cancer Res 5:19\u201327","journal-title":"Gastrointest Cancer Res"},{"key":"2633_CR3","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1136\/gutjnl-2011-300810","volume":"61","author":"I Badiola","year":"2012","unstructured":"Badiola I, Olaso E, Crende O, Friedman SL, Vidal-Vanaclocha F (2012) Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis. Gut 61:1465\u20131472. doi: 10.1136\/gutjnl-2011-300810","journal-title":"Gut"},{"key":"2633_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-1-4419-6033-7_5","volume":"155","author":"N Bellam","year":"2010","unstructured":"Bellam N, Pasche B (2010) Tgf-beta signaling alterations and colon cancer. Cancer Treat Res 155:85\u2013103. doi: 10.1007\/978-1-4419-6033-7_5","journal-title":"Cancer Treat Res"},{"key":"2633_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2009.11.008","volume":"21","author":"B Bierie","year":"2010","unstructured":"Bierie B, Moses HL (2010) Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev 21:49\u201359. doi: 10.1016\/j.cytogfr.2009.11.008","journal-title":"Cytokine Growth Factor Rev"},{"key":"2633_CR6","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.3748\/wjg.v20.i22.6786","volume":"20","author":"G Binefa","year":"2014","unstructured":"Binefa G, Rodr\u00edguez-Moranta F, Teule A, Medina-Hayas M (2014) Colorectal cancer: from prevention to personalized medicine. World J Gastroenterol 20:6786\u20136808. doi: 10.3748\/wjg.v20.i22.6786","journal-title":"World J Gastroenterol"},{"key":"2633_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/neuonc\/noq142","volume":"13","author":"U Bogdahn","year":"2011","unstructured":"Bogdahn U, Hau P, Stockhammer G, Venkataramana NK, Mahapatra AK, Suri A, Balasubramaniam A, Nair S, Oliushine V, Parfenov V, Poverennova I, Zaaroor M, Jachimczak P, Ludwig S, Schmaus S, Heinrichs H, Schlingensiepen KH, Trabedersen Glioma Study Group (2011) Targeted therapy for high-grade glioma with the TGF-\u03b22 inhibitor trabedersen: results of a randomized and controlled phase IIb study. Neuro-Oncology 13:132\u2013142. doi: 10.1093\/neuonc\/noq142","journal-title":"Neuro-Oncology"},{"key":"2633_CR8","doi-asserted-by":"crossref","unstructured":"Caestecker MP de, Piek E, Roberts AB (2000) Role of transforming growth factor-beta signaling in cancer. J Natl Cancer Inst 92:1388\u20131402","DOI":"10.1093\/jnci\/92.17.1388"},{"key":"2633_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.semcancer.2013.12.008","volume":"25","author":"A Calon","year":"2014","unstructured":"Calon A, Tauriello DVBE (2014) TGF-beta in CAF-mediated tumor growth and metastasis. Semin Cancer Biol 25:15\u201322. doi: 10.1016\/j.semcancer.2013.12.008","journal-title":"Semin Cancer Biol"},{"key":"2633_CR10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ccr.2012.08.013","volume":"22","author":"A Calon","year":"2012","unstructured":"Calon A, Espinet E, Palomo-Ponce S, Tauriello DV, Iglesias M, C\u00e9spedes MV, Sevillano M, Nadal C, Jung P, Zhang XH, Byrom D, Riera A, Rossell D, Mangues R, Massagu\u00e9 J, Sancho E, Batlle E (2012) Dependency of colorectal cancer on a TGF-\u03b2-driven program in stromal cells for metastasis initiation. Cancer Cell 22:571\u2013584. doi: 10.1016\/j.ccr.2012.08.013","journal-title":"Cancer Cell"},{"key":"2633_CR11","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ng.3225","volume":"47","author":"A Calon","year":"2015","unstructured":"Calon A, Lonardo E, Berenguer-Llergo A, Espinet E, Hernando-Momblona X, Iglesias M, Sevillano M, Palomo-Ponce S, Tauriello DV, Byrom D, Cortina C, Morral C, Barcel\u00f3 C, Tosi S, Riera A, Attolini CS, Rossell D, Sancho E, Batlle E (2015) Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat Genet 47:320\u2013329. doi: 10.1038\/ng.3225","journal-title":"Nat Genet"},{"key":"2633_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0085398","volume":"9","author":"X Chen","year":"2014","unstructured":"Chen X, Yang Y, Zhou Q, Weiss JM, Howard OZ, McPherson JM, Wakefield LM, Oppenheim JJ (2014) Effective chemoimmunotherapy with anti-TGF\u03b2 antibody and cyclophosphamide in a mouse model of breast cancer. PLoS One 9:1\u201310. doi: 10.1371\/journal.pone.0085398","journal-title":"PLoS One"},{"key":"2633_CR13","doi-asserted-by":"publisher","first-page":"9063","DOI":"10.1200\/JCO.2005.04.4669","volume":"23","author":"G Chong","year":"2005","unstructured":"Chong G, Cunningham D (2005) Improving long-term outcomes for patients with liver metastases from colorectal cancer. J Clin Oncol 23:9063\u20139066. doi: 10.1200\/JCO.2005.04.4669","journal-title":"J Clin Oncol"},{"key":"2633_CR14","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.2174\/138920111798808284","volume":"12","author":"EC Connolly","year":"2011","unstructured":"Connolly EC, Akhurst RJ (2011) The complexities of TGF-\u03b2 action during mammary and squamous cell carcinogenesis. Curr Pharm Biotechnol 12:2138\u20132149","journal-title":"Curr Pharm Biotechnol"},{"key":"2633_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jmb.2005.10.022","volume":"355","author":"G De Crescenzo","year":"2006","unstructured":"De Crescenzo G, Hinck CS, Shu Z, Z\u00fa\u00f1iga J, Yang J, Tang Y, Baardsnes J, Mendoza V, Sun L, L\u00f3pez-Casillas F, O\u2019Connor-McCourt M, Hinck AP (2006) Three key residues underlie the differential affinity of the TGFbeta isoforms for the TGFbeta type II receptor. J Mol Biol 355:47\u201362. doi: 10.1016\/j.jmb.2005.10.022","journal-title":"J Mol Biol"},{"key":"2633_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/ng1001-117","volume":"29","author":"R Derynck","year":"2001","unstructured":"Derynck R, Akhurst RJ, Balmain A (2001) TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29:117\u2013129. doi: 10.1038\/ng1001-117","journal-title":"Nat Genet"},{"key":"2633_CR17","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1242\/dev.121.6.1845","volume":"121","author":"MC Dickson","year":"1995","unstructured":"Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ (1995) Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121:1845\u20131854","journal-title":"Development"},{"key":"2633_CR18","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1158\/1078-0432.CCR-06-0162","volume":"12","author":"R Ge","year":"2006","unstructured":"Ge R, Rajeev V, Ray P, Lattime E, Rittling S, Medicherla S, Protter A, Murphy A, Chakravarty J, Dugar S, Schreiner G, Barnard N, Reiss M (2006) Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo. Clin Cancer Res 12:4315\u20134330. doi: 10.1158\/1078-0432.CCR-06-0162","journal-title":"Clin Cancer Res"},{"key":"2633_CR19","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/mt.2015.43","volume":"23","author":"M Ghisoli","year":"2015","unstructured":"Ghisoli M, Barve M, Schneider R, Mennel R, Lenarsky C, Wallraven G, Pappen BO, LaNoue J, Kumar P, Nemunaitis D, Roth A, Nemunaitis J, Whiting S, Senzer N, Fletcher FA, Nemunaitis J (2015) Pilot trial of FANG immunotherapy in Ewing\u2019s sarcoma. Mol Ther J Am Soc Gene Ther 23:1103\u20131109. doi: 10.1038\/mt.2015.43","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"2633_CR20","doi-asserted-by":"publisher","unstructured":"Giaccone G, Bazhenova LA, Nemunaitis J, Tan M, Juh\u00e1sz E, Ramlau R, Heuvel MM van den, Lal R, Kloecker GH, Eaton KD, Chu Q, Dunlop DJ, Jain M, Garon EB, Davis CS, Carrier E, Moses SC, Shawler DL, Fakhrai H (2015) A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer. Eur J Cancer 51:2321\u20132329. doi: 10.1016\/j.ejca.2015.07.035","DOI":"10.1016\/j.ejca.2015.07.035"},{"key":"2633_CR21","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1074\/jbc.M002016200","volume":"276","author":"H Gille","year":"2001","unstructured":"Gille H, Kowalski J, Li B, LeCouter J, Moffat B, Zioncheck TF, Pelletier N, Ferrara N (2001) Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2): a reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem 276:3222\u20133230. doi: 10.1074\/jbc.M002016200","journal-title":"J Biol Chem"},{"key":"2633_CR22","doi-asserted-by":"publisher","unstructured":"Gonzalez-Zubeldia I, Dotor J, Redrado M, Bleau AM, Manrique I, Aberasturi AL de, Villalba M, Calvo A (2015) Co-migration of colon cancer cells and CAFs induced by TGF\u03b21 enhances liver metastasis. Cell Tissue Res 359:829\u2013839. doi: 10.1007\/s00441-014-2075-6","DOI":"10.1007\/s00441-014-2075-6"},{"key":"2633_CR23","doi-asserted-by":"publisher","unstructured":"Guinney J, Dienstmann R, Wang X, Reyni\u00e8s A de, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda G, Angelino P, Bot BM, Morris JS, Simon IM, Gerster S, Fessler E, De Sousa E Melo F, Missiaglia E, Ramay H, Barras D, Homicsko K, Maru D, Manyam GC, Broom B, Boige V, Perez-Villamil B, Laderas T, Salazar R, Gray JW, Hanahan D, Tabernero J, Bernards R, Friend SH, Laurent-Puig P, Medema JP, Sadanandam A, Wessels L, Delorenzi M, Kopetz S, Vermeulen L, Tejpar S (2015) The consensus molecular subtypes of colorectal cancer. Nat Med 21:1350\u20131356. doi: 10.1038\/nm.3967","DOI":"10.1038\/nm.3967"},{"key":"2633_CR24","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.2147\/DDDT.S86621","volume":"9","author":"S Herbertz","year":"2015","unstructured":"Herbertz S, Sawyer JS, Stauber AJ, Gueorguieva I, Driscoll KE, Estrem ST, Cleverly AL, Desaiah D, Guba SC, Benhadji KA, Slapak CA, Lahn MM (2015) Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway. Drug Des Dev Ther 9:4479\u20134499. doi: 10.2147\/DDDT.S86621","journal-title":"Drug Des Dev Ther"},{"key":"2633_CR25","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.2174\/138920111798808383","volume":"12","author":"AP Hinck","year":"2011","unstructured":"Hinck AP, O\u2019Connor-McCourt MD (2011) Structures of TGF-\u03b2 receptor complexes: implications for function and therapeutic intervention using ligand traps. Curr Pharm Biotechnol 12:2081\u20132098","journal-title":"Curr Pharm Biotechnol"},{"key":"2633_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/jb\/mvs089","volume":"152","author":"M Horiguchi","year":"2012","unstructured":"Horiguchi M, Ota M, Rifkin DB (2012) Matrix control of transforming growth factor-\u03b2 function. J Biochem 152:321\u2013329. doi: 10.1093\/jb\/mvs089","journal-title":"J Biochem"},{"key":"2633_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.gde.2010.12.004","volume":"21","author":"GJ Inman","year":"2011","unstructured":"Inman GJ (2011) Switching TGF\u03b2 from a tumor suppressor to a tumor promoter. Curr Opin Genet Dev 21:93-99. doi: 10.1016\/j.gde.2010.12.004","journal-title":"Curr Opin Genet Dev"},{"key":"2633_CR28","first-page":"507","volume":"26","author":"M Isaksson-Mett\u00e4vainio","year":"2006","unstructured":"Isaksson-Mett\u00e4vainio M, Palmqvist R, Forssell J, Stenling R, Oberg A (2006) SMAD4\/DPC4 expression and prognosis in human colorectal cancer. Anticancer Res 26:507\u2013510","journal-title":"Anticancer Res"},{"key":"2633_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-015-1119-y","volume":"15","author":"Q Ji","year":"2015","unstructured":"Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L, Jiang H, Ren J, Cai J, Li Q (2015) Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-\u03b21\/Smads signaling pathway mediated snail\/E-cadherin expression. BMC Cancer 15:1\u201312. doi: 10.1186\/s12885-015-1119-y","journal-title":"BMC Cancer"},{"key":"2633_CR30","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/ng1295-415","volume":"11","author":"V Kaartinen","year":"1995","unstructured":"Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J (1995) Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 11:415\u2013421. doi: 10.1038\/ng1295-415","journal-title":"Nat Genet"},{"key":"2633_CR31","doi-asserted-by":"publisher","unstructured":"Kodach LL, Wiercinska E, Miranda NFCC de, Bleuming SA, Musler AR, Peppelenbosch MP, Dekker E, Brink GR van den, Noesel CJ van, Morreau H, Hommes DW, Ten Dijke P, Offerhaus GJ, Hardwick JC (2008) The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers. Gastroenterology 134:1332\u20131341. doi: 10.1053\/j.gastro.2008.02.059","DOI":"10.1053\/j.gastro.2008.02.059"},{"key":"2633_CR32","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.ejca.2010.02.040","volume":"46","author":"M Korpal","year":"2010","unstructured":"Korpal M, Kang Y (2010) Targeting the transforming growth factor-beta signalling pathway in metastatic cancer. Eur J Cancer 46:1232\u20131240. doi: 10.1016\/j.ejca.2010.02.040","journal-title":"Eur J Cancer"},{"key":"2633_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/521754","volume":"2014","author":"J Krstic","year":"2014","unstructured":"Krstic J, Santibanez JF (2014) Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells. Sci World J 2014:1\u201314. doi: 10.1155\/2014\/521754","journal-title":"Sci World J"},{"key":"2633_CR34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cytogfr.2009.07.002","volume":"20","author":"HG Laverty","year":"2009","unstructured":"Laverty HG, Wakefield LM, Occleston NL, O\u2019Kane S, Ferguson MW (2009) TGF-beta3 and cancer: a review. Cytokine Growth Factor Rev 20:305\u2013317. doi: 10.1016\/j.cytogfr.2009.07.002","journal-title":"Cytokine Growth Factor Rev"},{"key":"2633_CR35","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1158\/0008-5472.CAN-05-2448","volume":"66","author":"L Maggio-Price","year":"2006","unstructured":"Maggio-Price L, Treuting P, Zeng W, Tsang M, Bielefeldt-Ohmann H, Iritani BM (2006) Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Res 66:828\u2013838. doi: 10.1158\/0008-5472.CAN-05-2448","journal-title":"Cancer Res"},{"key":"2633_CR36","doi-asserted-by":"publisher","unstructured":"Mao J-H, Saunier EF, Koning JP de, McKinnon MM, Higgins MN, Nicklas K, Yang HT, Balmain A, Akhurst RJ (2006) Genetic variants of Tgfb1 act as context-dependent modifiers of mouse skin tumor susceptibility. Proc Natl Acad Sci U S A 103:8125\u20138130. doi: 10.1073\/pnas.0602581103","DOI":"10.1073\/pnas.0602581103"},{"key":"2633_CR37","doi-asserted-by":"publisher","unstructured":"Marisa L, Reyni\u00e8s A de, Duval A, Selves J, Gaub MP, Vescovo L, Etienne-Grimaldi MC, Schiappa R, Guenot D, Ayadi M, Kirzin S, Chazal M, Fl\u00e9jou JF, Benchimol D, Berger A, Lagarde A, Pencreach E, Piard F, Elias D, Parc Y, Olschwang S, Milano G, Laurent-Puig P, Boige V (2013) Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med 10:e1001453. doi: 10.1371\/journal.pmed.1001453","DOI":"10.1371\/journal.pmed.1001453"},{"key":"2633_CR38","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm3434","volume":"13","author":"J Massagu\u00e9","year":"2012","unstructured":"Massagu\u00e9 J (2012) TGF\u03b2 signalling in context. Nat Rev Mol Cell Biol 13:616\u2013630. doi: 10.1038\/nrm3434","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2633_CR39","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00262-015-1681-9","volume":"64","author":"J Medina-Echeverz","year":"2015","unstructured":"Medina-Echeverz J, Vasquez M, Gomar C, Ardaiz N, Berraondo P (2015) Overexpression of apolipoprotein A-I fused to an anti-transforming growth factor beta peptide modulates the tumorigenicity and immunogenicity of mouse colon cancer cells. Cancer Immunol Immunother 64:717\u2013725. doi: 10.1007\/s00262-015-1681-9","journal-title":"Cancer Immunol Immunother"},{"key":"2633_CR40","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1158\/1535-7163.MCT-07-0337","volume":"7","author":"D Melisi","year":"2008","unstructured":"Melisi D, Ishiyama S, Sclabas GM, Fleming JB, Xia Q, Tortora G, Abbruzzese JL, Chiao PJ (2008) LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis. Mol Cancer Ther 7:829\u2013840. doi: 10.1158\/1535-7163.MCT-07-0337","journal-title":"Mol Cancer Ther"},{"key":"2633_CR41","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1158\/0008-5472.CAN-10-2651","volume":"71","author":"KS Mohammad","year":"2011","unstructured":"Mohammad KS, Javelaud D, Fournier PGJ, Niewolna M, McKenna CR, Peng XH, Duong V, Dunn LK, Mauviel A, Guise TA (2011) TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases. Cancer Res 71:175\u2013184. doi: 10.1158\/0008-5472.CAN-10-2651","journal-title":"Cancer Res"},{"key":"2633_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090353","author":"JC Morris","year":"2014","unstructured":"Morris JC, Tan AR, Olencki TE, Shapiro GI, Dezube BJ, Reiss M, Hsu FJ, Berzofsky JA, Lawrence DP (2014) Phase I study of GC1008 (Fresolimumab): a human anti-transforming growth factor-beta (TGF\u03b2) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma. PLoS One. doi: 10.1371\/journal.pone.0090353","journal-title":"PLoS One"},{"key":"2633_CR43","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.3748\/wjg.v22.i23.5301","volume":"22","author":"N Mukaida","year":"2016","unstructured":"Mukaida N, Sasaki S (2016) Fibroblasts, an inconspicuous but essential player in colon cancer development and progression. World J Gastroenterol 22:5301. doi: 10.3748\/wjg.v22.i23.5301","journal-title":"World J Gastroenterol"},{"key":"2633_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/cr.2008.316","volume":"19","author":"D Padua","year":"2009","unstructured":"Padua D, Massagu\u00e9 J (2009) Roles of TGFbeta in metastasis. Cell Res 19:89\u2013102. doi: 10.1038\/cr.2008.316","journal-title":"Cell Res"},{"key":"2633_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbcan.2006.06.004","volume":"1775","author":"K Pardali","year":"2007","unstructured":"Pardali K, Moustakas A (2007) Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta Rev Cancer 1775:21\u201362. doi: 10.1016\/j.bbcan.2006.06.004","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2633_CR46","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.canlet.2014.05.006","volume":"351","author":"CY Park","year":"2014","unstructured":"Park CY, Min KN, Son JY, Park SY, Nam JS, Kim DK, Sheen YY (2014) An novel inhibitor of TGF-\u03b2 type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition. Cancer Lett 351:72\u201380. doi: 10.1016\/j.canlet.2014.05.006","journal-title":"Cancer Lett"},{"key":"2633_CR47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ccr.2009.02.011","volume":"15","author":"S Pe\u00f1uelas","year":"2009","unstructured":"Pe\u00f1uelas S, Anido J, Prieto-S\u00e1nchez RM, Folch G, Barba I, Cuartas I, Garc\u00eda-Dorado D, Poca MA, Sahuquillo J, Baselga J, Seoane J (2009) TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 15:315\u2013327. doi: 10.1016\/j.ccr.2009.02.011","journal-title":"Cancer Cell"},{"key":"2633_CR48","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nrc3603","volume":"13","author":"M Pickup","year":"2013","unstructured":"Pickup M, Novitskiy S, Moses HL (2013) The roles of TGF\u03b2 in the tumour microenvironment. Nat Rev Cancer 13:788\u2013799. doi: 10.1038\/nrc3603","journal-title":"Nat Rev Cancer"},{"key":"2633_CR49","first-page":"497","volume":"7","author":"A Picon","year":"1998","unstructured":"Picon A, Gold LI, Wang J, Cohen A, Friedman E (1998) A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1. Cancer Epidemiol Biomarkers Prev 7:497\u2013504","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2633_CR50","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1073\/pnas.92.10.4254","volume":"92","author":"DF Pierce","year":"1995","unstructured":"Pierce DF, Gorska AE, Chytil A, Meise KS, Page DL, Coffey RJ Jr, Moses HL (1995) Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc Natl Acad Sci U S A 92:4254\u20134258","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2633_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/djt369","volume":"106","author":"DR Principe","year":"2014","unstructured":"Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, Pasche B, Lee C, Grippo PJ (2014) TGF-\u03b2: duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst 106:1\u201316. doi: 10.1093\/jnci\/djt369","journal-title":"J Natl Cancer Inst"},{"key":"2633_CR52","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/ng1295-409","volume":"11","author":"G Proetzel","year":"1995","unstructured":"Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MW, Doetschman T (1995) Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet 11:409\u2013414. doi: 10.1038\/ng1295-409","journal-title":"Nat Genet"},{"key":"2633_CR53","doi-asserted-by":"publisher","first-page":"18151","DOI":"10.3748\/wjg.v20.i48.18151","volume":"20","author":"H Raskov","year":"2014","unstructured":"Raskov H, Pommergaard H-C, Burcharth J, Rosenberg J (2014) Colorectal carcinogenesis\u2014update and perspectives. World J Gastroenterol 20:18151\u201318164. doi: 10.3748\/wjg.v20.i48.18151","journal-title":"World J Gastroenterol"},{"key":"2633_CR54","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fonc.2014.00120","volume":"4","author":"M Raval","year":"2014","unstructured":"Raval M, Bande D, Pillai AK, Blaszkowsky LS, Ganguli S, Beg MS, Kalva SP (2014) Yttrium-90 radioembolization of hepatic metastases from colorectal cancer. Front Oncol 4:120. doi: 10.3389\/fonc.2014.00120","journal-title":"Front Oncol"},{"key":"2633_CR55","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1242\/dev.124.13.2659","volume":"124","author":"LP Sanford","year":"1997","unstructured":"Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T (1997) TGF\u03b22 knockout mice have multiple developmental defects that are non-overlapping with other TGF\u03b2 knockout phenotypes. Development 124:2659\u20132670","journal-title":"Development"},{"key":"2633_CR56","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.semcancer.2012.04.001","volume":"22","author":"CWR Scheel","year":"2012","unstructured":"Scheel CWR (2012) Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol 22:396\u2013403. doi: 10.1016\/j.semcancer.2012.04.001","journal-title":"Semin Cancer Biol"},{"key":"2633_CR57","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4062\/biomolther.2013.072","volume":"21","author":"YY Sheen","year":"2013","unstructured":"Sheen YY, Kim MJ, Park SA, Park SY, Nam JS (2013) Targeting the transforming growth factor-\u03b2 signaling in cancer therapy. Biomol Ther 21:323\u2013331. doi: 10.4062\/biomolther.2013.072","journal-title":"Biomol Ther"},{"key":"2633_CR58","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"YMJ Shi","year":"2003","unstructured":"Shi YMJ (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685\u2013700","journal-title":"Cell"},{"key":"2633_CR59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A (2016) Cancer statistics. CA Cancer J Clin 66:7\u201330. doi: 10.3322\/caac.21332","journal-title":"CA Cancer J Clin"},{"key":"2633_CR60","doi-asserted-by":"publisher","first-page":"e1073","DOI":"10.1038\/cddis.2014.49","volume":"5","author":"C Stolfi","year":"2014","unstructured":"Stolfi C, De Simone V, Colantoni A, Franz\u00e8 E, Ribichini E, Fantini MC, Caruso R, Monteleone I, Sica GS, Sileri P, MacDonald TT, Pallone F, Monteleone G (2014) A functional role for Smad7 in sustaining colon cancer cell growth and survival. Cell Death Dis 5:e1073. doi: 10.1038\/cddis.2014.49","journal-title":"Cell Death Dis"},{"key":"2633_CR61","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(00)81132-0","volume":"92","author":"K Takaku","year":"1998","unstructured":"Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM (1998) Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92:645\u2013656","journal-title":"Cell"},{"key":"2633_CR62","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1002\/ijc.24961","volume":"126","author":"S Takaku","year":"2010","unstructured":"Takaku S, Terabe M, Ambrosino E, Peng J, Lonning S, McPherson JM, Berzofsky JA (2010) Blockade of TGF-beta enhances tumor vaccine efficacy mediated by CD8(+) T cells. Int J Cancer 126:1666\u20131674. doi: 10.1002\/ijc.24961","journal-title":"Int J Cancer"},{"key":"2633_CR63","first-page":"1258","volume":"7","author":"H Tsushima","year":"2001","unstructured":"Tsushima H, Ito N, Tamura S, Matsuda Y, Inada M, Yabuuchi I, Imai Y, Nagashima R, Misawa H, Takeda H, Matsuzawa Y, Kawata S (2001) Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer. Clin Cancer Res 7:1258\u20131262","journal-title":"Clin Cancer Res"},{"key":"2633_CR64","doi-asserted-by":"publisher","unstructured":"Van Meeteren LA, Ten Dijke P (2012) Regulation of endothelial cell plasticity by TGF-\u03b2. Cell Tissue Res 347:177\u2013186. doi: 10.1007\/s00441-011-1222-6","DOI":"10.1007\/s00441-011-1222-6"},{"key":"2633_CR65","doi-asserted-by":"publisher","first-page":"18551","DOI":"10.1074\/jbc.M111.338103","volume":"287","author":"LA Van Meeteren","year":"2012","unstructured":"Van Meeteren LA, Thorikay M, Bergqvist S, Pardali E, Stampino CG, Hu-Lowe D, Goumans MJ, Ten Dijke P (2012) Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting. J Biol Chem 287:18551\u201318561. doi: 10.1074\/jbc.M111.338103","journal-title":"J Biol Chem"},{"key":"2633_CR66","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12307-011-0084-5","volume":"4","author":"F Vidal-Vanaclocha","year":"2011","unstructured":"Vidal-Vanaclocha F (2011) The liver prometastatic reaction of cancer patients: implications for microenvironment-dependent colon cancer gene regulation. Cancer Microenviron 4:163\u2013180. doi: 10.1007\/s12307-011-0084-5","journal-title":"Cancer Microenviron"},{"key":"2633_CR67","doi-asserted-by":"publisher","unstructured":"Voorneveld PW, Kodach LL, Jacobs RJ, Noesel CJ van, Peppelenbosch MP, Korkmaz KS, Molendijk I, Dekker E, Morreau H, Pelt GW van, Tollenaar RA, Mesker W, Hawinkels LJ, Paauwe M, Verspaget HW, Geraets DT, Hommes DW, Offerhaus GJ, Brink GR van den, Ten Dijke P, Hardwick JC (2015) The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC. Br J Cancer 112:122\u2013130. doi: 10.1038\/bjc.2014.560","DOI":"10.1038\/bjc.2014.560"},{"key":"2633_CR68","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nrc3500","volume":"13","author":"LM Wakefield","year":"2013","unstructured":"Wakefield LM, Hill CS (2013) Beyond TGF\u03b2: roles of other TGF\u03b2 superfamily members in cancer. Nat Rev Cancer 13:328\u2013341. doi: 10.1038\/nrc3500","journal-title":"Nat Rev Cancer"},{"key":"2633_CR69","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9621","author":"X Wang","year":"2016","unstructured":"Wang X, Solban N, Khanna P, Callea M, Song J, Alsop DC, Pearsall RS, Atkins MB, Mier JW, Signoretti S, Alimzhanov M, Kumar R, Bhasin MK, Bhatt RS (2016) Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma. Oncotarget. doi: 10.18632\/oncotarget.9621","journal-title":"Oncotarget"},{"key":"2633_CR70","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.canlet.2008.11.035","volume":"277","author":"B Zhang","year":"2009","unstructured":"Zhang B, Halder SK, Zhang S, Datta PK (2009) Targeting transforming growth factor-beta signaling in liver metastasis of colon cancer. Cancer Lett 277:114\u2013120. doi: 10.1016\/j.canlet.2008.11.035","journal-title":"Cancer Lett"},{"key":"2633_CR71","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1053\/j.gastro.2009.11.004","volume":"138","author":"B Zhang","year":"2010","unstructured":"Zhang B, Halder SK, Kashikar ND, Cho YJ, Datta A, Gorden DL, Datta PK (2010) Antimetastatic role of Smad4 signaling in colorectal cancer. Gastroenterology 138:969\u201380.e1\u20133. doi: 10.1053\/j.gastro.2009.11.004","journal-title":"Gastroenterology"},{"key":"2633_CR72","doi-asserted-by":"publisher","unstructured":"Zubeldia IG, Bleau A-M, Redrado M, Serrano D, Agliano A, Gil-Puig C, Vidal-Vanaclocha F, Lecanda J, Calvo A (2013) Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGF\u03b21-targeting peptides P17 and P144. Exp Cell Res 319:12\u201322. doi: 10.1016\/j.yexcr.2012.11.004","DOI":"10.1016\/j.yexcr.2012.11.004"}],"container-title":["Cell and Tissue Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00441-017-2633-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-017-2633-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-017-2633-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T20:03:58Z","timestamp":1692821038000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00441-017-2633-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,30]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["2633"],"URL":"https:\/\/doi.org\/10.1007\/s00441-017-2633-9","relation":{},"ISSN":["0302-766X","1432-0878"],"issn-type":[{"value":"0302-766X","type":"print"},{"value":"1432-0878","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,30]]}}}